Regarding BP report and valuation for
Mayne. 56c . I still have in my mind our
CEO on indicating April 2021 as Expected
FDA approval for E4. They also state this
month.
This is in contrast to CEO of Mithra Pharma
they being the Global owner, manufacturer
and Distributor of product. He said only a
couple Of days ago they expected by June
end probably late May for FDA approval.
I only wish SR being our CEO would inform
Moir shareholders some clarification to this
most important forecast.
Regarding BP report and valuation forMayne. 56c . I still have...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.25 |
Change
-0.150(2.78%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.35 | $5.41 | $5.19 | $1.239M | 231.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $5.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.36 | 1000 | 1 |
View Market Depth
| Last trade - 16.11pm 25/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |